Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-09-03 16:32:27 ET · period of report 2026-09-03 · accession 0001231589-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-03 16:32 | 2026-09-03 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-09-03 16:32 | 2026-09-03 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $482.03 | -8,300 | 45.2K | -16% | -$4.00M |
| DT | 2026-09-03 16:32 | 2026-09-03 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -8,300 | 55.8K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-03 | M | A | 8,300 | $146.03 | 53,472 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 2 | Common | Common Stock | 2026-09-03 | S | D | 1,545 | $478.93 | 51,927 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $478.23 to $479.225. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-09-03 | S | D | 936 | $479.66 | 50,991 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $479.24 to $480.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-09-03 | S | D | 2,360 | $480.86 | 48,631 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $480.26 to $481.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-09-03 | S | D | 1,048 | $481.92 | 47,583 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $481.34 to $482.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-09-03 | S | D | 160 | $482.66 | 47,423 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $482.38 to $482.875. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-09-03 | S | D | 200 | $483.85 | 47,223 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $483.42 to $484.115. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-09-03 | S | D | 954 | $485.12 | 46,269 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F8) This transaction was executed in multiple trades at prices ranging from $484.81 to $485.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2026-09-03 | S | D | 598 | $486.47 | 45,671 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F9) This transaction was executed in multiple trades at prices ranging from $486.025 to $487.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2026-09-03 | S | D | 169 | $487.36 | 45,502 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F10) This transaction was executed in multiple trades at prices ranging from $487.06 to $487.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Common | Common Stock | 2026-09-03 | S | D | 10 | $488.32 | 45,492 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 12 | Common | Common Stock | 2026-09-03 | S | D | 320 | $490.88 | 45,172 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 13 | Derivative | Stock Option | 2026-09-03 | M | D | 8,300 | $0.00 | 55,840 | D | $146.03 · 2020-03-15 to 2027-03-15 | 8,300 Common Stock | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |